image
Arrowhead Pharmaceuticals, Inc. ARWR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 19.93
-1.48 %
$ 2.48 B
Market Cap
-3.99
P/E
BALANCE SHEET
1.14 B ASSETS
48.89%
Growth Rates
1Year 48.89%
3Years 17.08%
5Years 26.65%
7Years 40.78%
10Years 20.08%
949 M LIABILITIES
98.32%
Growth Rates
1Year 98.32%
3Years 46.57%
5Years 55.07%
7Years 69.96%
10Years 49.66%
185 M EQUITY
-31.66%
Growth Rates
1Year -31.66%
3Years -23.16%
5Years -5.39%
7Years 12.48%
10Years 1.08%
BALANCE SHEET DECOMPOSITION
Balance Sheet Arrowhead Pharmaceuticals, Inc.
image
Current Assets 695 M
Cash & Short-Term Investments 681 M
Receivables 0
Other Current Assets 14.5 M
Non-Current Assets 444 M
Long-Term Investments 0
PP&E 431 M
Other Non-Current Assets 13 M
Current Liabilities 103 M
Accounts Payable 11.4 M
Short-Term Debt 6.34 M
Other Current Liabilities 85.4 M
Non-Current Liabilities 846 M
Long-Term Debt 504 M
Other Non-Current Liabilities 341 M

Balance Sheet

Millions
Sep-2024 Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015 Sep-2014 Sep-2013 Sep-2012 Sep-2011 Sep-2010 Sep-2009 Sep-2008 Sep-2007 Sep-2006 Sep-2005 Sep-2004 Sep-2003 Sep-2002 Sep-2001 Sep-2000 Sep-1999 Sep-1998 Sep-1997
ASSETS
Cash & Cash Equivalents 102.7 110.9 108.0 184.4 143.6 221.8 30.1 24.8 85.4 81.2 132.5 19.1 3.4 7.5 6.8 2.0 10.1 24.1 28.0 22.5 8.6 1.4 18.5 K 271 1.95 K 124 1.02 K 1.16 K
Short Term Investments 578.3 292.7 268.4 183.4 171.9 36.9 46.4 40.8 0 17.5 21.7 9.0 0.1 0.6 0 0 0 0 0 76.9 K 0.5 0 0 0 0 0 0 0
Receivables 0 0 1.4 10.3 0.8 0.7 0.3 67.8 K 75 K 0 0 75 K 2.5 1.6 0.9 0.1 86.6 K 0.3 74.2 K 33.4 K 51.8 K 0 0 640 1.28 K 11.3 K 3.18 K 10.4 K
Inventory 0 0 (21.6) 4.4 4.3 3.3 1.3 0.9 1.3 0 0 0 0 0 0.2 0 0 0 0 0 0 0 13 K 5.92 K 12.2 K 14.3 K 22.5 K 21.7 K
Other Current Assets 14.5 15.9 27.5 6.6 6.0 5.9 1.9 2.2 5.1 4.1 0.6 0.6 0.6 0.1 0.4 0.3 0.4 0.9 0.7 0.2 0.4 0.2 627 39 K 628 627 8.67 K 800
Total Current Assets 695.5 419.5 376.4 384.6 322.4 265.2 78.8 67.9 90.5 102.9 154.8 28.8 6.6 9.9 8.1 2.5 10.6 25.3 28.8 22.8 9.5 1.5 32.1 K 45.9 K 16.1 K 26.3 K 29.5 K 34.1 K
PP&E 431.3 335.6 168.6 66.0 47.0 23.2 13.9 15.5 15.4 4.5 3.9 3.5 4.9 25.4 K 0.1 0.5 1.2 1.4 1.3 1.1 0.9 2.02 K 31.4 K 446 49.1 K 55.9 K 49.1 K 64.1 K
Intangible Assets 8.6 10.3 12.0 13.7 15.4 17.1 18.8 20.5 22.2 24.8 1.0 3.2 4.8 1.7 2.0 2.4 2.7 2.9 3.4 5.0 1.5 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.0 1.8 0.4 0 0 0 0 0 0 0
Long Term Investments 0 0 105.9 245.6 137.5 44.2 0 0 0 0 23.1 1.7 0 1.8 2.0 2.2 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 4.5 0.2 29.1 0.3 0.3 0.1 0.1 0.1 0.1 45.8 K 41.4 K 1.7 0.3 2.4 34.7 K 0.1 2.7 0.2 0.2 0.1 75.4 K 0 0 0 0 0 6.13 K 9.44 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 139.8 765.6 691.9 710.1 522.5 349.8 111.6 104.0 128.2 132.3 182.8 37.3 16.5 15.9 12.4 7.7 17.3 29.9 34.5 29.0 11.9 1.5 63.6 K 46.3 K 65.1 K 82.3 K 84.8 K 0.1
LIABILITIES
Accounts Payable 11.4 35.9 2.9 9.5 6.8 7.6 2.8 4.1 12.2 5.0 2.6 1.2 0.9 0.6 0.7 1.0 1.3 1.3 0.8 0.5 0.5 92.7 K 0.3 0.2 0.2 0.2 1.4 1.4
Short Term Debt 6.3 9.7 5.6 4.5 1.1 0 0.2 0.2 0.2 0.2 0.3 1.2 0.3 0 0.5 0.7 0.8 0 0 0 0 0 0.6 0.5 0.5 0.5 1.0 1.0
Other Current Liabilities 85.4 58.2 100.4 33.3 32.8 11.7 9.3 14.4 13.2 10.5 8.9 6.2 4.1 2.0 3.1 0.6 1.6 1.4 2.1 0.4 0.1 3.49 K 0.7 0.6 0.5 0.3 0.2 0.2
Total Current Liabilities 103.2 105.5 74.1 146.5 40.7 97.1 12.4 18.7 25.6 15.9 11.8 8.7 5.3 2.6 4.3 2.3 3.7 2.9 2.9 1.0 0.7 96.2 K 1.6 1.3 1.2 1.0 2.7 2.7
Long Term Debt 504.2 372.9 78.8 23.3 20 063.2 0 2.1 2.3 2.5 0.5 0.8 1.1 2.1 0.6 0 0.5 0.7 0 0 0 0 0 27.5 K 33 K 39 K 43 K 45 K 0
Deferred Tax Income 0 0 0 (131.5) 0 0 0 0 2.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 341.4 0 0 0 (20 043.2) 3.7 1.9 2.1 2.5 6.2 4.2 1.8 0.3 0.1 0 0 0.5 0.5 0 0 0 0 0 0 0 0 1 0
Total Liabilities 948.7 478.4 586.0 301.3 60.7 105.8 16.4 23.2 33.2 22.6 16.8 11.6 7.7 3.3 4.3 2.8 5.0 3.4 2.9 1.0 0.7 96.2 K 1.6 1.4 1.2 1.1 2.7 2.7
EQUITY
Common Stock 0.2 0.2 106.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 86.4 K 71.7 K 56.4 K 43 K 38.6 K 34.2 K 28 K 13.6 K 4.68 K 5.28 K 5.28 K 5.06 K 4.91 K 3.29 K 3.19 K
Retained Earnings (1 625.5) (1 026.0) (820.8) (644.7) (503.8) (419.3) (487.3) (432.8) (398.4) (316.7) (224.8) (166.1) (135.0) (113.9) (110.7) (105.0) (85.5) (58.4) (28.5) (9.2) (2.6) 95.2 K (9.6) (9.4) (9.2) (9.0) (9.5) (9.4)
Other Accumulative Comprehensive Income/Loss 4.8 (3.2) (0.1) 69 K 18.4 K (0.4) 21.6 K 33.2 K 7.45 K (0.1) (4.2) (3.1) (1.6) (0.3) (1.2) (1.0) (1.6) (1.7) (1.1) (0.7) (0.2) 90 81.8 K 10.6 K 69.2 K 61.5 K 92 K 77 K
Total Equity 191.1 287.2 125.8 408.8 461.8 244.0 95.2 80.9 95.0 109.6 166.0 25.7 8.8 12.6 8.1 4.9 12.3 26.5 31.6 28.0 11.2 1.4 (1.6) (1.3) (1.1) (1.0) (2.6) (2.6)
Total Liabilities and Equity 1 139.8 765.6 691.9 710.1 522.5 349.8 111.6 104.0 128.2 132.3 182.8 37.3 16.5 15.9 12.4 7.7 17.3 29.9 34.5 29.0 11.9 1.5 63.6 K 46.3 K 65.1 K 82.3 K 84.8 K 0.1
SHARES OUTSTANDING
Common Shares Outstanding 119.8 107.3 105.4 103.7 100.7 93.9 83.6 73.1 61.0 57.4 46.9 24.0 11.1 7.2 6.4 4.5 3.9 3.6 3.2 2.5 1.3 0.4 7.58 K 7.15 K 7.06 K 6.09 K 5.08 K 4.87 K